CIK: 0000310158 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $276,277 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | LAVA THERAPEUTICS NV | 1,149,345 | $1,793 | 0.6% | $0.95 | — | — | N51517105 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SUTRO BIOPHARMA INC | 272,351 (-90.0%) | $3,151 (+33.2%) | 1.1% | $1.84 | — | COM | 869367102 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PSNL | PERSONALIS INC | 14,044,943 | $111,798 | 40.5% | $4.62 | +89.5% | COM | 71535D106 |
| KYMR | KYMERA THERAPEUTICS INC | 772,165 | $60,082 | 21.7% | $45.17 | +49.5% | COM | 501575104 |
| MRNA | MODERNA INC | 2,308,190 | $68,069 | 24.6% | $47.80 | -43.2% | COM | 60770K107 |
| — | ENTRADA THERAPEUTICS INC | 1,739,768 | $17,885 | 6.5% | $17.29 | — | COM | 29384C908 |
| ALEC | ALECTOR INC | 3,545,719 | $5,531 | 2.0% | $3.76 | -52.9% | COM | 014442107 |
| — | EVAXION BIOTECH A/S | 1,214,126 | $5,791 | 2.1% | $1.40 | — | SPONSORED ADS | 29970R204 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 93,414 | $2,907 | 1.1% | $21.74 | +26.1% | COM | 92790C104 |
| CARM | CARISMA THERAPEUTICS INC | 1,473,240 | $63 | 0.0% | $0.82 | -91.1% | COM | 14216R101 |
| XLO | XILIO THERAPEUTICS INC | 1,483,758 | $950 | 0.3% | $0.98 | -23.6% | COM | 98422T100 |
| NEUP | NEUPHORIA THERAPEUTICS INC | 10,027 | $39 | 0.0% | $3.53 | +101.1% | COM | 64136E102 |
| HURA | TUHURA BIOSCIENCES | 13,950 | $11 | 0.0% | $3.38 | -43.4% | COM | 898920103 |